Furthermore, USP10 plays a role in attenuating hepatic steatosis in nonalcoholic steatohepatitis (NASH) through the promotion of autophagy, which alleviates hepatic steatosis, inflammation, and fibrosis (75). Here, USP10 is linked to fatty liver disease.